SCHEDULE OF IDENTIFIABLE INTANGIBLE ASSETS CARRYING VALUE (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Restructuring Cost and Reserve [Line Items]
Total	$ 39,251	$ 39,251
Accumulated Amortization	(32,500)	(31,964)
Net Carrying Value	6,751	7,287
CLIA Lab [Member]
Restructuring Cost and Reserve [Line Items]
Total	$ 609	609
Finite lived intangible asset, useful life	2 years 3 months 18 days
Asuragen Acquisition [Member] | Thyroid [Member]
Restructuring Cost and Reserve [Line Items]
Total	$ 8,519	8,519
Finite lived intangible asset, useful life	9 years
RedPath Acquisition [Member] | Pancreas Test [Member]
Restructuring Cost and Reserve [Line Items]
Total	$ 16,141	16,141
Finite lived intangible asset, useful life	7 years
RedPath Acquisition [Member] | Barrett's Test [Member]
Restructuring Cost and Reserve [Line Items]
Total	$ 6,682	6,682
Finite lived intangible asset, useful life	9 years
BioPharma Acquisition [Member] | Trademarks [Member]
Restructuring Cost and Reserve [Line Items]
Total	$ 1,600	1,600
Finite lived intangible asset, useful life	10 years
BioPharma Acquisition [Member] | Customer Relationships [Member]
Restructuring Cost and Reserve [Line Items]
Total	$ 5,700	$ 5,700
Finite lived intangible asset, useful life	8 years